Table 3.
All | < 50 years | > 50 years | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | S | I | R | P value | |
CEZ | 95 | 2.5 | 2.4 | 89.3 | 7.1 | 3.6 | 96.4 | 1.4 | 2.2 | 0.268 |
ABPC | 76.6 | 0.6 | 22.8 | 75.0 | 0 | 25.0 | 76.9 | 0.8 | 22.3 | 0.560 |
LVFX | 87.4 | 12.6 | 0 | 89.3 | 0 | 10.7 | 87.0 | 0 | 13.0 | 0.616 |
ST | 98 | 0 | 2 | 85.7 | 0 | 14.3 | 100 | 0 | 0 | 0.137 |
AMK | 98.8 | 1.2 | 0 | 100 | 0 | 0 | 98.6 | 0 | 1.4 | 1 |
FOM | 98.8 | 0 | 1.2 | 100 | 0 | 0 | 100 | 0 | 0 | 1 |
S Susceptible, I Intermediate, R Resistant, ABPC Ampicillin, CEZ Cefazolin, LVFX Levofloxacin, ST Sulfamethoxazole/trimethoprim, AMK Amikacin, FOM Fosfomycin